0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Picture of the Month—Diagnosis FREE

[+] Author Affiliations

Section Editor: Samir S Shah, MD, MSCE

More Author Information
Arch Pediatr Adolesc Med. 2011;165(5):465-466. doi:10.1001/archpediatrics.2011.50-b.
Text Size: A A A
Published online

Plain radiographs of the right hip showed a large, round, soft-tissue density overlying the right iliac bone. Pelvic magnetic resonance imaging demonstrated heterogeneous signal enhancement within the right iliac bone extending into the sacroiliac joint and lateral aspect of the right sacrum with associated irregular periosteal reaction and destructive lesions. The soft-tissue component extended into the surrounding tissues, including L5 to S1, without invading the spinal canal and measured approximately 17 × 9.4 × 9.0 cm (Figure 2). Because primary bone malignancy was suspected, a biopsy of the right iliac lesion was performed; pathology revealed Ewing sarcoma. Subsequent evaluation to determine the extent of disease included a bone marrow biopsy, full-body bone scan, and a chest computed tomography. The bone marrow biopsy specimen showed normocellular marrow without evidence of tumor. Bone scan showed an active osteoblastic process isolated to the right iliac bone and sacroiliac joint, without evidence of metastatic bone disease. The computed tomograph of the chest showed mediastinal lymphadenopathy with multiple pulmonary nodules consistent with hematogenous spread of malignancy.

Place holder to copy figure label and caption
Figure 2.

Magnetic resonance T2-weighted coronal image of the pelvis demonstrating a large heterogeneous destructive mass of the right iliac bone with significant soft tissue extension, without invasion of vertebral bodies. Arrows indicate heterogeneous destructive mass of the right iliac bone with significant soft-tissue extension.

Graphic Jump Location

Primary bone tumors are the sixth most common neoplasm in children, with Ewing sarcoma being the second most common bone tumor in children.1 Median age of presentation is 15 years, but Ewing sarcoma has been reported in all age groups. Ewing sarcoma is slightly more common in males.2 This malignancy may affect any bone, with those of the lower extremity being the most common sites of origin (45%) followed by pelvic involvement in 20% to 27% of cases.1 At the time of diagnosis, 26% to 28% of patients have metastatic disease, most commonly to the lungs, bones, and bone marrow.3

Patients typically present with localized pain and swelling and occasionally a palpable soft-tissue mass. Up to 28% of patients will have constitutional symptoms (ie, fever, weight loss, and malaise).1 Patients with large pelvic tumors may have bowel or bladder dysfunction, while paraspinal tumors may cause back pain and neurologic impairment, and thoracopulmonary tumors (Askin tumors) usually present with respiratory symptoms.4 A delay in diagnosis is common with Ewing sarcoma, as symptoms are nonspecific and physical examination findings are often limited until tumor bulk is significant.

Laboratory study evaluation is also nonspecific; patients may have elevations of the erythrocyte sedimentation rate, lactate dehydrogenase levels, or white blood cell count. On plain radiographs, Ewing sarcoma appears as an ill-defined, mottled, moth-eaten, destructive bone lesion, with periosteal reaction resembling an onion skin, and an associated soft-tissue mass.5 All patients require thorough evaluation for additional tumor burden to guide appropriate intervention. Magnetic resonance imaging evaluation helps to assess tumor size. Computed tomography of the chest is the best method to evaluate for metastatic disease, while a full-body bone scan assists in detection of skin lesions near the primary lesion and distant bone metastases. Bone marrow biopsy is recommended to exclude widespread metastatic disease of the bone marrow.

Metastatic disease is the most unfavorable prognostic feature of Ewing sarcoma. Patients with isolated pulmonary metastases have a slightly better outcome than those with bone or bone marrow metastases at initial diagnosis.3 Due to the high rate of metastatic disease at diagnosis, most patients are initially treated with neoadjuvant systemic multidrug chemotherapy, followed by local surgical resection, radiotherapy, or both. At 5 years after diagnosis, overall survival for patients with localized disease is 82%, while it is only 39% in those with metastases.4

This article highlights the importance of including oncologic processes in the differential diagnosis of children with limb pain, limp, or both to allow for prompt diagnosis and initiation of therapy given the potential morbidity and mortality of advanced disease.

Return to Quiz Case.

Correspondence: Eron Y. Friedlaender, MD, MPH, Division of Emergency Medicine, The Children's Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA 19104 (friedlaender@email.chop.edu).

Accepted for Publication: July 22, 2010.

Financial Disclosure: None reported.

Additional Contributions: Victor Ho, MD, Department of Radiology at the Children's Hospital of Philadelphia, assisted with the radiographic images.

Grier  HE The Ewing family of tumors: Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am 1997;44 (4) 991- 1004
PubMed Link to Article
Gurney  JGSwensen  ARBulterys  M Malignant bone tumors. Ries  LAGSmith  MAGurney  JG  et al.  Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995.  Bethesda, MD National Cancer Institute, SEER Program1999;99- 110NIH Publication 99-4649
Esiashvili  NGoodman  MMarcus  RB  Jr Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol 2008;30 (6) 425- 430
PubMed Link to Article
Maheshwari  AVCheng  EY Ewing sarcoma family of tumors. J Am Acad Orthop Surg 2010;18 (2) 94- 107
PubMed
Morrissy  RWeinstein  S Lovell and Winter's Pediatric Orthopaedics. 6th ed Philadelphia, PA Lippincott Williams & Wilkins2006;530- 531

Figures

Place holder to copy figure label and caption
Figure 2.

Magnetic resonance T2-weighted coronal image of the pelvis demonstrating a large heterogeneous destructive mass of the right iliac bone with significant soft tissue extension, without invasion of vertebral bodies. Arrows indicate heterogeneous destructive mass of the right iliac bone with significant soft-tissue extension.

Graphic Jump Location

Tables

References

Grier  HE The Ewing family of tumors: Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am 1997;44 (4) 991- 1004
PubMed Link to Article
Gurney  JGSwensen  ARBulterys  M Malignant bone tumors. Ries  LAGSmith  MAGurney  JG  et al.  Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995.  Bethesda, MD National Cancer Institute, SEER Program1999;99- 110NIH Publication 99-4649
Esiashvili  NGoodman  MMarcus  RB  Jr Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol 2008;30 (6) 425- 430
PubMed Link to Article
Maheshwari  AVCheng  EY Ewing sarcoma family of tumors. J Am Acad Orthop Surg 2010;18 (2) 94- 107
PubMed
Morrissy  RWeinstein  S Lovell and Winter's Pediatric Orthopaedics. 6th ed Philadelphia, PA Lippincott Williams & Wilkins2006;530- 531

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles